Here are five key notes:
1. The two companies combined will strengthen Orchid’s position as a leading orthopedic coating company. The acquisition adds new and novel coating technologies, geographic reach and an expanded customer base.
2. The combination creates an integrated local supply chain in Europe including castings and forgings to fully finished, coated and packaged implants.
3. Alhenia’s coating portfolio includes coatings on PEEK and polyethylene, ceramic coatings, cold spray coatings, titanium on metal and ceramic and anti-bacterial coatings.
4. Alhenia is based in Switzerland and employs around 60 people. Orchid has 14 facilities worldwide and is focused on orthopedic and medical device technology.
“We are convinced that Orchid is the perfect platform to further expand the technologies and markets that Alhenia has developed in the last years, offering attractive opportunities for our specialized team and customers in the near future,” said Alhenia founders Jorge Garcia and Armando Salito.
More articles on orthopedic devices:
Rise in knee replacements in younger patients
Bluegrass Orthopaedics & Hand Care implements the Navio system
Medtronic Q1 revenue soars 12%, Core spine flat
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
